CoChat
Cited by 204

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Cystatin C as a Risk Factor for Outcomes in Chronic Kidney Disease

Menon, Vandana, Shlipak, Michael G., Wang, Xuelei, Coresh, Josef, Greene, Tom, Stevens, Lesley, Kusek, John W., Beck, Gerald J., Collins, Allan J., Levey, Andrew S., Sarnak, Mark J. · 2007 · Annals of Internal Medicine

Abstract

BACKGROUND: No study has compared cystatin C level, serum creatinine concentration, and estimated glomerular filtration rate (GFR) as risk factors for outcomes in chronic kidney disease (CKD), and none has compared measured GFR with CKD in any population. OBJECTIVE: To compare cystatin C level with serum creatinine concentration and iothalamate GFR as risk factors for death and kidney failure. DESIGN: Observational study using serum cystatin C assayed from baseline samples of the Modification of Diet in Renal Disease Study (1989-1993). SETTING: 15 clinical centers in the United States that participated in the Modification of Diet in Renal Disease Study. PARTICIPANTS: 825 trial participants with stage 3 or 4 nondiabetic CKD who had measurements of serum cystatin C. MEASUREMENTS: All-cause mortality, cardiovascular (CVD) mortality, and kidney failure until December 2000. RESULTS: Mean cystatin C level, creatinine concentration, and GFR were 2.2 mg/L (SD, 0.7), 212.16 micromol/L (SD, 88.4) (2.4 mg/dL [SD, 1.0]), and 33 mL/min per 1.73 m2 (SD, 12), respectively. Median follow-up was 10 years. Twenty-five percent of patients (n = 203) died of any cause, 15% (n = 123) died of CVD, and 66% (n = 548) reached kidney failure. In multivariate-adjusted models, 1-SD decreases in 1/creatinine, GFR, and 1/cystatin C were associated with increased risks for all-cause mortality of 1.27 (95% CI, 1.06 to 1.49), 1.27 (CI, 1.08 to 1.49), and 1.41 (CI, 1.18 to 1.67), respectively. For CVD mortality, the increased risks were 1.32 (CI, 1.05 to 1.64), 1.28 (CI, 1.04 to 1.59), and 1.64 (CI, 1.28 to 2.08), respectively. For kidney failure, the increased risks were 2.81 (CI, 2.48 to 3.18), 2.41 (CI, 2.15 to 2.70), and 2.36 (CI, 2.10 to 2.66), respectively. LIMITATION: The Modification of Diet in Renal Disease Study cohort may not be representative of all patients with nondiabetic CKD because participants were more likely to reach kidney failure than death in follow-up. CONCLUSION: The association of cystatin C level with all-cause and CVD mortality was as strong as or perhaps stronger than that of iothalamate GFR with these outcomes in stage 3 or 4 CKD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7326/0003-4819-147-1-200707030-00004

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 204

Metadata

Authors
Menon, V., Shlipak, M. G., Wang, X., Coresh, J., Greene, T., Stevens, L., Kusek, J. W., Beck, G. J., Collins, A. J., Levey, A. S., & Sarnak, M. J.
Venue
Annals of Internal Medicine
Published
2007-07-03
Volume
147
Issue
1
Pages
19-27
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2125327064
Cited by
204
References
2
FWCI
10.81
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cystatin C as a Risk Factor for Outcomes in Chronic Kidney Disease. https://app.cochat.ai/papers/10.7326/0003-4819-147-1-200707030-00004
The paper
Menon, V., Shlipak, M. G., Wang, X., Coresh, J., Greene, T., Stevens, L., Kusek, J. W., Beck, G. J., Collins, A. J., Levey, A. S., & Sarnak, M. J. (2007). Cystatin C as a Risk Factor for Outcomes in Chronic Kidney Disease. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-147-1-200707030-00004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.